• Skip to primary navigation
  • Skip to main content
Be Plant

Be Plant

Plant the Seed

  • Home
  • About
    • Get On Board
  • Education
  • Donate
  • Events
  • Store
  • Magazine
  • Contact Us
  • Show Search
Hide Search

Back

Alzheimer/Dementia

Studies

  • The therapeutic potential of the endocannabinoid system for Alzheimer’s disease
  • Endocannabinoid signalling in Alzheimer’s disease
  • A molecular link between the active component of marijuana and Alzheimer’s disease pathology
  • Neuroprotective effect of CBD… on beta-amyloid-induced toxicity in PC12 cells
  • The Potential Therapeutic Effects of THC on Alzheimer’s Disease
  • The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease 
  • CBD in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression 
  • CBD: A promising drug for neurodegenerative disorders?
  • Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
  • The role of the endocannabinoid system in Alzheimer’s disease
  • The role of phytochemicals in the treatment and prevention of dementia
  • Cannabinoids for the treatment of dementia
  • Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression inSHSY5YAPP+ Cells Through PPARγ Involvement
  • Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
  • Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia
  • Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
  • Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
  • Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
  • CBD Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
  • In vivo Evidence for Therapeutic Properties of CBD for Alzheimer’s Disease
  • Neurological aspects of medical use of CBD
  • Amyloid-beta inhibits E-S Potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition
  • Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
  • Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease
  • Alzheimer’s disease; taking the edge off with cannabinoids?
  • Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
  • Cannabinoids and Parkinson’s disease
  • Cannabinoids for the treatment of agitation and aggression in Alzheimer’s disease
  • Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
  • Cannabinoids for the treatment of dementia
  • Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease
  • CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease
  • Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
  • Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
  • Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
  • Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
  • Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation
  • Safety and efficacy of medical cannabis oil for behavioral and psychological symptoms of dementia: An-open label, add-on, pilot study
  • Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease
  • Synthetic cannabinoids in dementia with agitation: Case studies and literature review
  • The influence of cannabinoids on generic traits of neurodegeneration
  • The potential therapeutic effects of THC on Alzheimer’s disease
  • The role of the endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease

Be Plant

Copyright © 2021 · Be Plant · Log in